On March 10, 2022, Peter Kushner, Ph.D., Chief Scientific Officer of Olema Pharmaceuticals, Inc. and the Company agreed that Dr. Kushner would transition from CSO to Senior Research Fellow and Co-Founder, a non-executive role, effective April 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.13 USD | -1.20% | +35.64% | -6.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.41% | 734M | |
+51.85% | 57.87B | |
+41.53% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- OLMA Stock
- News Olema Pharmaceuticals, Inc.
- Peter Kushner, Chief Scientific Officer of Olema Pharmaceuticals, Inc. Announces Transition from CSO to Senior Research Fellow and Co-Founder, A Non-Executive Role, Effective April 1, 2022